Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Zydus Lifesciences has some good news — it has received final USFDA approval to sell Jaythari (Deflazacort) Tablets in America. This drug helps treat Duchenne muscular dystrophy (DMD ...

Zydus Lifesciences share price extended the gains on second day, rising 1 percent in the early trade on April 15 following United States Food and Drug Administration (USFDA) approval for Jaythari ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg (USRLD: Emflaza ...

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets in four strengths - 6 mg, 18 mg, 30 mg, and 36 mg. The ...

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) on Friday, April 11, announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Jaythari (Deflazacort) ...

Benchmark Indian indices surged on April 11, with Sensex rising over 1,300 points and Nifty 50 up nearly 2 percent following a relief rally on US President Trump's 90-day pause on tariffs, which ...